SENTRYX

SentryX is a clinical stage biopharmaceutical company developing a non-opioid platform for the treatment of acute pain after surgery. SentryX was founded in 2017 as a spin-out from the University Medical Center Utrecht, where co-founder prof. dr. Jorrit-Jan Verlaan works as a spine surgeon... SentryX is a dynamic team with people from different personal and professional backgrounds who enjoy taking the initiative and coming up with creative solutions for complex problems. People with technical, clinical, and regulatory expertise work together to bring local therapies from the bench to the bedside.

Also known as: SentryX B.V.

Registration numbers: 70207410 (W)

Primary location: Utrecht Netherlands